tiprankstipranks
Quantum-Si Incorporated (QSI)
NASDAQ:QSI
US Market
Want to see QSI full AI Analyst Report?

Quantum-Si (QSI) Earnings Dates, Call Summary & Reports

1,863 Followers

Earnings Data

Report Date
Aug 10, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.11
Last Year’s EPS
-0.16
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 07, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized materially de-risking technical progress for the Proteus platform (successful integrated sequencing, increased amino acid detection, doubled read lengths, PTM strategy) and showed strong early customer engagement and a solid cash runway (~$190M) that supports development through launch. However, near-term revenue remains very small ($258k Q1; ~ $1M outlook for 2026), and the company faces significant R&D/commercialization spend and execution required to scale manufacturing and convert interest into sales. On balance, the advances on Proteus and financial runway are compelling positives, while near-term commercial and burn risks merit monitoring.
Company Guidance
The company reiterated 2026 is a “transition year” and gave explicit financial guidance: total revenue of approximately $1.0 million, adjusted operating expenses of $98 million or less, and total cash usage of $93 million or less; as of 03/31/2026 it held $190.4 million in cash, cash equivalents and marketable securities, which management said supports operations into 2028 (roughly 1½ years after the estimated Proteus launch). Quarterly metrics included Q1 revenue of $258k, gross profit of $74k (29% gross margin), GAAP operating expenses of $24.1M (vs. $25.6M PY) and adjusted operating expenses of $21.4M (vs. $22.9M PY), and dividend/interest income of $1.9M (vs. $2.5M PY). Operational guidance and cadence: near-term revenue driven by consumable utilization, modest new capital placements and Platinum placements with embedded Proteus upgrade credits; management expects to complete manufacturing scale-up and early-access deployments (a “handful” of sites by summer), to offer broader sample evaluations as internal Proteus instruments increase, and to achieve product milestones (17 amino acids detected today, up from 15 in Dec‑2025, targeting 18 at delivery and all 20 during 2026 with a 2027 sequencing kit detecting all 20).
Successful Proteus Sequencing Milestone
Completed sequencing on fully integrated Proteus instruments, demonstrating end-to-end automation (reagent prep to data analysis); this milestone materially de-risks the new platform and confirms fundamental technology performance ahead of commercial launch.
Increased Amino Acid Detection
Internal developmental sequencing kit detection increased from 15 amino acids in Dec 2025 to 17 amino acids in Apr/May 2026 (+2 amino acids, ~13.3% increase), with confidence to reach 18 at launch and demonstrate all 20 during 2026.
Substantially Improved Read Length and Throughput vs Platinum
Customer prototype comparisons showed Proteus delivering roughly double the average peptide read length (~+100%) and a much higher number of reads (higher chip feature density), translating into more sequence-level information per protein.
Progress on PTM Detection Strategy
Significant progress toward post‑translational modification (PTM) capabilities using kinetic signatures and AI-driven analysis, offering a universal sequencing chemistry approach that could expand applications beyond affinity‑based and mass spec methods.
Commercial Preparation and Early Market Interest
Launched Proteus roadshow program (April) with strong early engagement (example event: 35 attendees vs 25 registered), three customer manuscripts (preprint/peer review), five posters, and a customer podium presentation so far in 2026 — building awareness across academic, clinical, biopharma, and government segments.
Solid Cash Position and Extended Runway
Cash, cash equivalents, and marketable securities of $190.4M as of 03/31/2026; company reiterates cash runway into 2028 and guidance for 2026: revenue ~ $1M, adjusted operating expenses ≤ $98M, and total cash usage ≤ $93M, supporting development and launch activities.
Operating Expense Discipline
GAAP total operating expenses decreased to $24.1M from $25.6M year-over-year (≈ -5.9%), and adjusted operating expenses decreased to $21.4M from $22.9M (≈ -6.6%), reflecting prioritization of R&D for Proteus while trimming SG&A.
Insider and Board Confidence Signals
Insider activity noted as routine tax-related Form 4 mechanics; two board members purchased 600,000 shares in the quarter in open market, signaling board-level conviction.

Quantum-Si (QSI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

QSI Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 10, 2026
2026 (Q2)
-0.11 / -
-0.16
May 07, 2026
2026 (Q1)
-0.11 / -0.10
-0.119.09% (<+0.01)
Mar 03, 2026
2025 (Q4)
-0.12 / -0.08
-0.2365.22% (+0.15)
Nov 05, 2025
2025 (Q3)
-0.13 / -0.17
-0.185.56% (<+0.01)
Aug 05, 2025
2025 (Q2)
-0.14 / -0.16
-0.160.00% (0.00)
May 15, 2025
2025 (Q1)
-0.15 / -0.11
-0.1421.43% (+0.03)
Mar 03, 2025
2024 (Q4)
-0.18 / -0.23
-0.16-43.75% (-0.07)
Nov 12, 2024
2024 (Q3)
-0.20 / -0.18
-0.17-5.88% (>-0.01)
Aug 07, 2024
2024 (Q2)
-0.18 / -0.16
-0.1811.11% (+0.02)
May 09, 2024
2024 (Q1)
-0.20 / -0.14
-0.1717.65% (+0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

QSI Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 07, 2026
$0.98$0.91-7.55%
Mar 03, 2026
$0.95$0.91-4.01%
Nov 05, 2025
$1.80$1.65-8.33%
Aug 05, 2025
$1.44$1.37-4.86%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Quantum-Si Incorporated (QSI) report earnings?
Quantum-Si Incorporated (QSI) is schdueled to report earning on Aug 10, 2026, After Close (Confirmed).
    What is Quantum-Si Incorporated (QSI) earnings time?
    Quantum-Si Incorporated (QSI) earnings time is at Aug 10, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is QSI EPS forecast?
          QSI EPS forecast for the fiscal quarter 2026 (Q2) is -0.11.